ID: ALA5183083
Chembl Id: CHEMBL5183083
PubChem CID: 168280507
Max Phase: Preclinical
Molecular Formula: C14H12FN3O6S
Molecular Weight: 369.33
Associated Items:
Canonical SMILES: O=C(CN(c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccc(F)cc1)NO
Standard InChI: InChI=1S/C14H12FN3O6S/c15-10-4-6-13(7-5-10)25(23,24)17(9-14(19)16-20)11-2-1-3-12(8-11)18(21)22/h1-8,20H,9H2,(H,16,19)
Standard InChI Key: LLNIRUOKORBVLD-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 369.33 | Molecular Weight (Monoisotopic): 369.0431 | AlogP: 1.43 | #Rotatable Bonds: 6 |
| Polar Surface Area: 129.85 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 8.74 | CX Basic pKa: ┄ | CX LogP: 1.44 | CX LogD: 1.42 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.45 | Np Likeness Score: -2.17 |
| 1. Song WQ, Liu ML, Yuan LC, Li SY, Wang YN, Xiao ZP, Zhu HL.. (2022) Synthesis, evaluation and mechanism exploration of 2-(N-(3-nitrophenyl)-N-phenylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors., 78 [PMID:36332883] [10.1016/j.bmcl.2022.129043] |
Source(1):
